期刊文献+

高通量血液透析与序贯结合血液透析滤过清除β2微球蛋白的效果比较 被引量:3

Comparison on the efficacies of high flux hemodialysis and sequential combination of hemodiafiltration at different frequency on removing β2-microglobulin
下载PDF
导出
摘要 目的比较高通量血液透析(high flux hemodialysis,HFHD)与序贯结合不同频次血液透析滤过(hemodiafiltration,HDF)清除β2微球蛋白(β2-microglobulin,β2-MG)的效果。方法将52例维持性血液透析患者随机分为3组,分别为HFHD组(17例)、联合1组(17例)和联合2组(18例)。HFHD组:每周3次HFHD;联合1组:每2周5次HFHD+2周1次HDF;联合2组:每周2次HFHD+1周1次HDF,每次透析时间均为4 h。免疫比浊法比较三组0.5年及后1年的血清β2-MG的水平。结果三组不同时间段治疗后β微球蛋白均较透析前明显下降(P<0.05),联合2组β2-MG清除率最高,相比HFHD组,三组间β2-MG清除率有统计学差异(P<0.01)。结论 HFHD序贯结合不同频率HDF能提高患者血清β2-MG清除效果,序贯1周1次的较序贯2周1次的HDF效果更好。 Objective To compare the efficacies of hemodialysis and sequential combination hemodiafiltration at different frequency on removing serumβ2-microglobulin(β2-MG).Methods The 52 patients with maintenance hemodialysis were randomly divided into three groups:HFHD group(17 cases),No.1 combined group(17 cases)and No.2 combined group(18 cases);in HFHD group:HFHD 3 times per week;in No.1 combined group:HFHD+HDF 1 time/2w;in No.2 combined group:HFHD 3times/W+HDF once a week.The time of dialysis lasted 4 hours.The levels of serumβ2-MG were compared by immunoturbidimetry between three groups at six months and one year later.Results After above treatment,the levels ofβ-microglobulin in the three groups were significantly lower than those before dialysis(P<0.05),the No.2 combined group was the first in removing rate.Compared with HFHD group,the levels ofβ2-MG removing rate was statistically different(P<0.01).Conclusion HDHD combined with HDF at different frequency can improve the serumβ2-MG removing efficacy,the sequential once a week has better efficacy than the sequential 1 time per two weeks.
作者 吴其顺 王文燕 巢军 朱文芳 夏炎 何建强 WU Qi-shun;WANG Wen-yan;CHAO Jun(Department of Nephrology,the Affiliated Hospital to Jiangsu University,Zhenjiang,Jiangsu 212000,China)
出处 《实用医药杂志》 2018年第4期289-291,307,共4页 Practical Journal of Medicine & Pharmacy
关键词 高通量血液透析 Β2微球蛋白 血液透析滤过 High flux hemodialysis β2-MG Hemodiafiltration(HDF)
  • 相关文献

参考文献7

二级参考文献72

  • 1孙鲁英,王梅,杨莉.终末期肾脏病患者钙磷代谢及甲状旁腺激素水平的临床分析[J].北京大学学报(医学版),2005,37(2):147-150. 被引量:63
  • 2谢红浪,季大玺.On-line hemodiafiltration技术和临床应用[J].肾脏病与透析肾移植杂志,2005,14(4):377-381. 被引量:25
  • 3Dember LM, Jaber BL. Dialysis related amyloidosis: late finding or hidden epidemic[J]. Seminars in Dial, 2006,19: 105-109.
  • 4Jadoul M. Dialysis-related amyloidosis: importance of biocompatibility and age [J]. Nephrol Dial Transplant, 1998, 13:61 -64.
  • 5Farrell J, Bastani B. β 2- microglobulin amyloidosis in chronic dialysis patients: case report and review of the literature [J]. J Am Soc Nephrol, 1997, 8: 509-514.
  • 6Krieter DH, Lemke HD, Canaud B, et al.β 2 -microglobulin removal by extracorporeal renal replacement therapies [J]. Biochim Biophys Acta, 2005, 1753:146- 153.
  • 7Kutsuki H. β2- microglobulin selective direct hemoperfusion column for the treatment of dialysis related amyloidosis [J]. Biochim Biophys Acta, 2005, 1753:141-145.
  • 8Ameer GA, Grovender EA, Ploegh H, et al. A novel immunoadsorption device for removing β2-microglobulin from whole blood [J]. Kidney Int, 2001, 59: 1544-1550.
  • 9Copley JB, Lindberg JS. Nontransplant therapy for dialysis-related amyloidosis [J]. Seminars in Dial, 2001, 14:94- 98.
  • 10Eknoyan G, Beck GJ, Cheung AK, et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis [J]. N Engl J Med, 2002, 347:2010 -2019.

共引文献143

同被引文献23

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部